neoplasia News and Research

RSS

HPV vaccination reduces risk of cervical cancer

Vaccination against the human papilloma virus (HPV) reduces the risk of a condition that often leads to cervical cancer, according to an analysis of Danish health registry data.

5 Aug 2020

New cancer imaging system hastens cancer detection

A new study highlights a novel imaging system that utilizes near-infrared light, which makes the procedure less invasive and produces faster results.

24 Jul 2020

Novel imaging system can diagnose cancer more efficiently than conventional methods

Cancer diagnosis requires a lengthy process of multiple analyses of tissue biopsies, impeding the quick and early detection of cancers.

23 Jul 2020

Accelerating the Diagnosis and Treatment of Cancer with Mass-Spectrometry Based Techniques

An interview with Livia Eberlin, Assistant Professor at the University of Texas at Austin, discussing the development of mass-spectrometry based techniques for cancer diagnosis and improved clinical outcomes.

From Pittcon 16 Jun 2020

Targeted therapy pralsetinib shows high response rates in patients with RET fusion-positive cancers

The targeted therapy pralsetinib appears to have high response rates and durable activity in patients with a broad variety of tumors harboring RET gene fusions, according to results from the international Phase I/II ARROW trial, led by researchers at The University of Texas MD Anderson Cancer Center.

29 May 2020

YAP signal pathway plays a vital role in the onset of head-and-neck cancer

Joint research between Kobe University and National Hospital Organization Kyushu Cancer Center has revealed that mice with mutations in the YAP signal pathway develop head-and-neck cancer over an extremely short period of time (world's fastest cancer onset mouse model), indicating that this pathway plays a crucial role in the onset of these cancers.

25 Mar 2020

Immunotherapy treatment shows promise for some patients with advanced rare cancers

A study conducted by researchers at The University of Texas MD Anderson Cancer Center demonstrated acceptable toxicity and anti-tumor activity in patients with four types of advanced, hard-to-treat rare cancers.

20 Mar 2020

Immunosuppressive therapy does not increase risk of vulvar or vaginal cancer in women with IBD

In a new retrospective study, researchers found that the use of immunosuppressive therapy does not increase the occurrence or recurrence of vulvar or vaginal cancer in women with inflammatory bowel disease (IBD).

11 Mar 2020

Patients using copper IUDs have lower cervical cancer risk compared to LNG-IUS users

Patients who used copper intrauterine devices (Cu IUD) were found to have a lower risk of high-grade cervical neoplasms (cervical cancer) compared to users of the levonorgestrel-releasing intrauterine system (LNG-IUS), according to a Columbia study recently published in Obstetrics & Gynecology.

10 Mar 2020

Contagious cancers in the oceans much more common than once thought

Researchers have found that a type of cancer affecting shellfish is spreading across the Atlantic Ocean and spilling into the Pacific Ocean as well. The study titled, “A single clonal lineage of transmissible cancer identified in two marine mussel species in South America and Europe,” is published this week in the latest issue of the journal eLife.

28 Nov 2019

Cochrane review provides information on HPV vaccines and dose schedules in young women, men

New evidence published in the Cochrane Library today provides further information on the benefits and harms of different human papillomavirus vaccines and vaccine schedules in young women and men.

22 Nov 2019

Contraceptive drug effective in preventing and regressing cervical cancer in mice

A new study in The American Journal of Pathology, published by Elsevier, reports that medroxyprogesterone acetate (MPA), the active ingredient in the common contraceptive injection Depo-Provera, was effective in preventing the development of cervical cancer in mice with precancerous lesions.

12 Nov 2019

Infectious cancer spreads across mussels in South America and Europe, shows study

An infectious cancer that originated in one species of mussel growing in the Northern Hemisphere has spread to related mussels in South America and Europe, says a new study published today in eLife.

7 Nov 2019

Novel home testing kit for cervical cancer could replace Pap tests

A new method of cervical cancer screening which is designed to be done by women at home could bring down the rates of cervical cancer and associated deaths. The work, presented at the National Cancer Research Institute (NCRI) Conference 2019 in Glasgow, has attracted immense attention because of its feasibility and wide acceptance.

6 Nov 2019

Self-sampling could increase detection of cervical pre-cancer

A non-invasive test to detect cervical pre-cancer could increase participation rates in cervical cancer screening programs.

4 Nov 2019

Unique biomarker in urine may offer non-invasive means of detecting prostate cancer

A research study published in the journal Neoplasia and led by principal investigator Nallasivam Palanisamy, Ph.D., associate scientist in the Vattikuti Urology Institute at Henry Ford Health System, has identified a novel prostate cancer gene fusion involving the KLK4 protein coding gene and KLKP1 pseudogene.

3 Oct 2019

Dogs can suffer from same autoimmune encephalitis as humans, research reveals

Researchers from North Carolina State University have found that dogs can suffer from the same type of autoimmune encephalitis that people do. The finding could lead to better screening methods for diagnosis and possibly more effective treatments for canine encephalitis.

24 Sep 2019

Single test can predict progression of untreated precancerous cervical disease

A single test for women has been shown to aid in predicting which cases of precancerous cervical disease will become more serious, helping with decisions on whether or not surgery is needed, according to a study led by Queen Mary University of London.

31 Jul 2019

Study forms basis for therapeutic strategies to combat cancers caused by HMGA1a

The researchers led by Professor Raphael Stoll therefore expect their results to form a basis for future therapeutic strategies to combat cancers caused by HMGA1a.

30 Jul 2019

Chronic kidney disease patients are excluded from clinical trials

Kidney diseases affect 850 million people worldwide, a figure twice as high as that of diabetes. Yet patients with chronic kidney disease are still being excluded from clinical trials.

10 Jul 2019